Big Pharma

From big biopharma to biotech CEO, John Houston’s R&D journey highlights a fast-changing world
From big biopharma to biotech CEO, John Houston’s R&D journey highlights a fast-changing world
Endpoints
R&D
John Houston
Big Pharma
biotech
Arvinas
GSK
Bristol-Myers Squibb
Flag link:
Big pharma stands to make hundreds of billions of dollars from a handful of medical conditions
Big pharma stands to make hundreds of billions of dollars from a handful of medical conditions
Motley Fool
Big Pharma
viral hepatitis
respiratory disease
autoimmune disease
cardiovascular disease
pain
diabetes
cancer
Flag link:
Managing Revenue Growth (And Contraction) In Big Pharma: What Have We Learned In The Last 10 Years?
Managing Revenue Growth (And Contraction) In Big Pharma: What Have We Learned In The Last 10 Years?
Forbes
Big Pharma
revenue
Flag link:
Meet Bertrand Bodson, Novartis’ new global digital strategy maestro for all things Big Pharma
Meet Bertrand Bodson, Novartis’ new global digital strategy maestro for all things Big Pharma
Endpoints
Novartis
digital pharma
Big Pharma
Flag link:
Pharma's giants, new and old, tell more tales than their numbers show
Pharma's giants, new and old, tell more tales than their numbers show
Fierce Pharma
Big Pharma
JNJ
Pfizer
GSK
Roche
Novartis
Sanofi
Bristol-Myers Squibb
Flag link:
Big Pharma veterans at Pfizer, AstraZeneca join the great migration to biotech
Big Pharma veterans at Pfizer, AstraZeneca join the great migration to biotech
Endpoints
Pfizer
AstraZeneca
Big Pharma
biotech
Flag link:
7 Trends On How Big Pharma Uses Social Media
7 Trends On How Big Pharma Uses Social Media
Forbes
Big Pharma
social media
Flag link:
5 Big Pharma Stocks With the Best Drug Pipelines
5 Big Pharma Stocks With the Best Drug Pipelines
Motley Fool
Big Pharma
Roche
AstraZeneca
AbbVie
Gilead Sciences
JNJ
Flag link:
Big Pharma Share Buybacks Not Impacting R&D Budgets
Big Pharma Share Buybacks Not Impacting R&D Budgets
Forbes
Big Pharma
share repurchase
R&D
Flag link:
Big Pharma VCs jump in to back a $63M mission to tackle a genetic driver of Alzheimer’s
Big Pharma VCs jump in to back a $63M mission to tackle a genetic driver of Alzheimer’s
Endpoints
Big Pharma
venture capital
Alzheimer's disease
Flag link:
Big Pharma share prices jumped in the first half, except for BMS
Big Pharma share prices jumped in the first half, except for BMS
Fierce Pharma
Big Pharma
pharma stocks
Bristol-Myers Squibb
Flag link:
As Big Pharma Flocks to Science Exchange, Norwest Leads $28M Funding
As Big Pharma Flocks to Science Exchange, Norwest Leads $28M Funding
Xconomy
Big Pharma
Norwest
Science Exchange
Flag link:
5 Most Profitable Big Pharma Stocks on the Market Right Now
5 Most Profitable Big Pharma Stocks on the Market Right Now
Motley Fool
Big Pharma
Gilead Sciences
Amgen
Novartis
Biogen
Bristol-Myers Squibb
Flag link:
The myth of “leaner and meaner” pharma
The myth of “leaner and meaner” pharma
Endpoints
layoffs
hirings
R&D
staff
employees
Big Pharma
Flag link:
Big Pharma And Social Media: How To Avoid Trouble With The FDA
Big Pharma And Social Media: How To Avoid Trouble With The FDA
Forbes
Big Pharma
social media
FDA
Flag link:
How Big Pharma Might Be Cut Down To Size
How Big Pharma Might Be Cut Down To Size
Forbes
Big Pharma
drug pricing
Emflaza
Marathon Pharma
Flag link:
Trump's Pick to Lead FDA Has Backing of Big Pharma
Trump's Pick to Lead FDA Has Backing of Big Pharma
FOX Business
Scott Gottlieb
FDA
Donald Trump
Big Pharma
Flag link:
Epizyme: Why Is Big Pharma Interested In This Small Biotech?
Epizyme: Why Is Big Pharma Interested In This Small Biotech?
Seeking Alpha
Epizyme
Big Pharma
Flag link:
Hiding Data And Other Criticisms Of Big Pharma
Hiding Data And Other Criticisms Of Big Pharma
Forbes
Big Pharma
innovation
clinical trial data
physician payments
Flag link:
Meet the lawyer trying to pry drug pricing secrets out of Big Pharma
Meet the lawyer trying to pry drug pricing secrets out of Big Pharma
Stat
Big Pharma
drug pricing
Mylan Labs
EpiPen
insulin
Eli Lilly
Novo Nordisk
Sanofi
Flag link: